Unboxing KoCarbon Ag Antimicrobial Silver Carbon Wound Dressing Video

Indication:General trauma, abrasions, post-surgical wounds / diabetes mellitus, pressure sores and other chronic wounds / first & second-degree burns / wounds caused by tumors or chemotherapy / wounds at the donor site and graft site / intubation site / full thickness & partial-thickness wounds

KoCarbonAg Antimicrobial Silver Carbon Wound Dressing is a new generation silver activated carbon fiber dressing clinically proven to provide antimicrobial effect.
KoCarbonAg Antimicrobial Silver Carbon Wound Dressing™ is designed for infectious acute/chronic wounds and difficult wounds. The lining (wound contact layer) of KoCarbonAg® Antimicrobial Dressing™ is primarily composed of PET non-woven fabric, silver activated carbon fiber fabric and PE membrane. The Antimicrobial Dressing contains silver at a level of 0.1 mg/cm2. When in contact with the wound, the bandage will provide excellent absorption and moisturizing effect to absorb blood exudate and bacteria and provide a moist environment for the wound. The silver ions in the dressing can inhibit the growth of bacteria absorbed by the dressing from the wound, and form an antimicrobial barrier that prevents infection and reduces wound odor.
The activated carbon fiber in the KoCarbonAg® Antimicrobial Silver Carbon Wound Dressing™ can moisturize the wound. It creates a moist environment for the wound to recover and shortens healing time. The dressing can be cut into the size of the wound. The low adhesion wound contact layer can effectively reduce the adhesion with the wound and reduce the pain when changing the dressing.

FREE SILVERSORB, MEPILEX, ACTICOAT, SILVERLON

LEARN ABOUT KOCARBON AG ANTIMICROBIAL SILVER CARBON WOUND DRESSING

INDICATION: GENERAL TRauma, abrasions, post-surgical wounds / diabetes mellitus, pressure sores and other chronic wounds / first & second-degree burns / wounds caused by tumors or chemotherapy / wounds at the donor site and graft site / intubation site / full thickness & partial-thickness wounds

KoCarbonAg Antimicrobial Silver Carbon Wound Dressing is a new generation silver activated carbon fiber dressing clinically proven to provide antimicrobial effect.

KoCarbonAg Antimicrobial Silver Carbon Wound Dressing™ is designed for infectious acute/chronic wounds and difficult wounds. The lining (wound contact layer) of KoCarbonAg® Antimicrobial Dressing™ is primarily composed of PET non-woven fabric, silver activated carbon fiber fabric and PE membrane. The Antimicrobial Dressing contains silver at a level of 0.1 mg/cm2. When in contact with the wound, the bandage will provide excellent absorption and moisturizing effect to absorb blood exudate and bacteria and provide a moist environment for the wound. The silver ions in the dressing can inhibit the growth of bacteria absorbed by the dressing from the wound, and form an antimicrobial barrier that prevents infection and reduces wound odor.

The activated carbon fiber in the KoCarbonAg® Antimicrobial Silver Carbon Wound Dressing™ can moisturize the wound. It creates a moist environment for the wound to recover and shortens healing time. The dressing can be cut into the size of the wound. The low adhesion wound contact layer can effectively reduce the adhesion with the wound and reduce the pain when changing the dressing.

kocarbon Ag Silver Wound Dressing Kit

Features

1. Provides protection and kills all kinds of bacteria

It is indicated for infectious wounds and will not induce drug-resistance; relieves pain, improves wound healing and promotes epithelialization.

Provides 97.92% bactericidal effect on the multidrug-resistant Acinetobacter baumannii [AB bacterium] and 99.99% bactericidal effect on both drug-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa.

Kocarbon Silver with Carbon layer wound dressing attacking bacterial DNA

2. Microporous Structure

Absorbs bacteria and tissue exudate from the wound, and reduces wound odor.

3. Blocks ultraviolet radiation, and prevents pigmentation

4 Shortens wound healing time, and cuts down medical costs

5.Porous and moisturizing, and provides a moist environment for wound healing

6. Does not affect X-ray or MRI examination

silver_activated_carbon_fiber_three_layers.png

Indications

  • Partial and full thickness wounds
  • Pressure ulcers
  • Diabetic ulcers
  • Surgical wounds
  • Acute wounds (1st and 2nd degree burns)

Contraindications

  1. To avoid adhesion at the wound, do not use the dressing with oil-based medicinal liquor.
  2. This product is unsuitable for individuals allergic to carbon fiber and silver.
  3. If the package is broken or the dressing structure separates into several layers before use, please contact the customer service. Do not use it.
  4. Pregnant women and newborns must follow the doctor’s instruction for use.
  5. This product contains silver ions that provide excellent antimicrobial effect and can effectively inhibit inflammatory response. However, please do not replace systemic treatment or other appropriate medical procedures of infection treatment with this product.

Precautions

  1. If black powders are found in the package or near the wound when changing the dressing (the black powders can be cleaned with normal saline), please do not worry as this is normal for activated carbon fiber.
  2. It is normal to feel tingling when using the bandage.
  3. It is advised to change the bandage based on the condition of the exudation. To avoid risk of infection, do not re-use the product.
  4. This product is for external use only.
  5. If redness, swelling, pain, or burning sensation occurs near the wound after use, please stop using the product and consult medical professionals.
  6. If PE membrane detaches from the bandage when changing the dressing, the dressing has absorbed too much exudate. It does not implicate a defect in the product. Please do not re-use the bandage.
  7. For third-degree burns, infectious wounds, wounds with exposed bones or tendons, or other conditions beyond the scope indicated by the original product design, please consult medical professionals to assess whether the product is appropriate for use in these wounds.
  8. After using the product in accordance with standard wound handling procedure, please consult medical professionals to re-assess the treatment plan if the wound appears abnormal.
  9. After use, please place the used product in the bag and dispose of it in non-recycle bin. Do not dispose of it carelessly.

Directions For Use

Please follow the instructions recommended by medical professionals.

Pre-treatment

  1. Please clean or shave the hair surrounding the wound depending on its condition in order to apply the dressing.
  2. Clean the wound with normal saline.
  3. Wipe and dry the skin around the wound.

Cover the wound

  1. Choose the size of the dressing that completely covers the wound (the dressing should have a diameter preferably 2~3 cm larger than the wound).
  2. With the black side facing the wound, apply the dressing to the wound.
  3. Use permeable tape or suitable bandage to secure the dressing to the appropriate location.
  4. For heavy exudate, use an extra layer of gauze on top of the dressing.

How to use the KOcarbon Ag Antimicobial Silver Carbon Wound Dressing

Remove/change dressing

  1. Lift the dressing gently by the four corners and remove it from the wound.
  2. If adhesion forms at the wound, please rinse the wound with proper amount of normal saline.
  3. When 80% of the dressing is saturated with exudates from the wound, please change the dressing in accordance with the method described above.

MPs have scrutinized the Department of Health and the NHS in England for being “too moderate” to act in forestalling and treating diabetes.

MPs have scrutinized the Department of Health and the NHS in England for being “too moderate” to act in forestalling and treating diabetes.

A report by the Public Accounts Committee says varieties being taken care of by both sort 1 and 2 diabetes mean the yearly cost to the wellbeing administration will keep on rising.

For individuals matured 16 and over the bill as of now stands at £5.5bn a year.

A NHS England representative said “diabetes care [was] beyond anyone’s imagination”.

In any case, he additionally said the heftiness fuelled hop in sort 2 diabetes debilitated to “overpower GP administrations”.

“…[It] puts the spotlight solidly on the requirement for no nonsense national activity on counteractive action by the NHS, government, managers, schools, and specifically the nourishment business,” he included.

‘Not keeping pace’

The panel said the quantity of grown-ups in England with diabetes has ascended to more than 3 million, and was going up by very nearly 5% consistently.

The quantity of individuals with diabetes is expanding, similar to the quantity of patients who create complexities

Meg Hillier, Chairwoman of the Public Accounts Committee

The legislature and NHS England had depicted an “unduly solid picture” of the condition of diabetes administrations, it included.

The vast majority of the £5.5bn-a-year expense is spent on inconveniences from diabetes, for example, heart and kidney infection, visual deficiency and nerve harm, prompting removals.

These can be minimized by coming down with the sickness early, and overseeing blood glucose, circulatory strain and cholesterol.

Yet, the board of trustees said that part of the issue arrived were “inadmissible varieties” in training, consideration and treatment of patients.

In addition, just 60% of patients get the yearly checks prescribed to keep them sound and avert long haul intricacies.

The report additionally said diabetes authority staffing levels in healing facilities “are not keeping pace” with the expanding rate of beds possessed by diabetes patients.

‘Targets not met’

It said: “The rate of beds in intense healing centers in England involved by individuals with diabetes keeps on ascending, from 14.8% in 2010 to 15.7% in 2013.

“Be that as it may, the level of diabetic authorities has not fundamentally changed over this period. In 2013, almost 33% of healing facilities in England participating in the review had no diabetes inpatient pro medical attendant and 6% did not have any expert time for diabetes inpatient care.

“NHS England let us know that an expansion in nursing numbers isn’t likely in the following year or two.”

Meg Hillier, executive of the board of trustees, said: “The NHS and Department for Health have been too moderate in handling diabetes, both in counteractive action and treatment.

“The quantity of individuals with diabetes is expanding, similar to the quantity of patients who create entanglements. It is an intense condition that can hugy affect individuals’ lives.”

She said citizens must have certainty that backing is accessible when and where they require it, “as opposed to by ethicalness of where they live”.

What is diabetes?

An unending illness, which happens when the pancreas does not create enough of the hormone insulin, or when the body can’t adequately utilize the insulin it produces

This prompts an expanded convergence of glucose in the blood (hyperglycaemia)

TYPE 1 diabetes is described by an absence of insulin generation

TYPE  2 diabetes is created by the body’s incapable utilization of insulin, and regularly comes about because of abundance body weight and physical idle

FREE SILVERSORB, MEPILEX, ACTICOAT, SILVERLON

How to care for your diabetic foot ulcer by Dr Udaya Kumar Maiya

diseases-diabetic-foot-THS

Covalon Presenting Its Latest Advanced Wound Care and Infection Control Products at Arab Health 2016

Covalon Presenting Its Latest Advanced Wound Care and Infection Control Products at Arab Health 2016

MISSISSAUGA, ON, Jan. 21, 2016 /CNW/ – Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV), an advanced medical technologies company, today announced it is presenting its latest line of advanced wound care and healthcare acquired infection control products from January 25th-28th at the Annual Arab Health Congress in Dubai, U.A.E. Arab Health provides an opportunity for Covalon to meet the 65,000 medical and scientific community attendees, medical product manufacturers, wholesalers and distributors from the Middle East, Asia, Europe, North America and most other regions of the world.

Covalon will be showcasing its category transforming products at Arab Health, including SurgiClear™ and IV Clear™ – breathable, clear, dual antimicrobial silicone adhesive surgical wound and vascular access securement dressings, as well as ColActive Plus Ag, a patented BioMatrix wound dressing available for use in most Middle Eastern jurisdictions.

“With this being our 5th year at the Arab Health Congress, we have shown not only our commitment to launching innovations into the region, but the region has shown us in return its willingness to be leaders in the adoption of new medical technologies that address its biggest healthcare challenges.” said John Hands, Covalon’s Senior Director of Global Marketing. “After rigorous evaluations by leading physicians and clinicians in Saudi Arabia, Qatar, Kuwait, UAE, Bahrain, Oman and other countries, our products have been successful in winning business in no less than 14 tenders this past year alone.  Covalon and our brands are becoming market leaders in the Middle East as a result of the hard work of our partners in the region, like Cure Development International Ltd.”

“We are pleased to represent Covalon and their portfolio of world-class products in the Gulf Cooperation Council (“GCC”) countries”, said Azzam Al Sulaim, Cure Development International, Ltd.’s Chief Executive Officer.  “The combination of our highly experienced clinical sales experts and Covalon’s life-saving products is providing needed advanced wound care, infection control and surgical dressing solutions to the GCC that are having a positive impact on clinicians and their patients.  We look forward to introducing more of Covalon’s products to the GCC as they become available.”

kocarbon ag antimicrobial silver carbon wound dressing

KoCarbon Ag Antimicrobial Silver Carbon Wound Dressing Information

Most Healthcare workers lack knowledge about diabetes

Study: Most workers lack knowledge about diabetes

MADURAI: A Diabetic Education and Prevention study conducted on workers in Tuticorin shows that there is prevalence of diabetes among 23% of the organized and unorganized workers and, of the total sample, only 30 per cent of the workers have knowledge of relevant and verified information regarding the disease.
The study tested the level of awareness that the workers had about diabetes mellitus and how correct the information they possessed was. It was based on pre-tested interview schedule; parameters such as level of information possessed, perception of risk, prevalence of diabetes, myths and misconceptions that prevail about diabetes and other general factors such as food intake, health status, etc., were tested.

genadyne npwt pump system buy back program

The results from this study show that diabetes is prevalent amongst 23 per cent of the workers while 10 per cent are at risk and in pre-diabetic stages. Among the diabetic, only 21 per cent regularly exercise and only 32 per cent of them take regular treatment for it. Seven per cent of the diabetic workers have never even considered any treatment for their disease. Fifty eight per cent of the patients say allopathic treatment is better for diabetes. Of the entire sample, only 30 per cent had correct information regarding what diabetes is and its effects. Ignorance about the disease is such that 74 per cent of the diabetic population consumes rice thrice a day. The study has brought to light the ubiquitous ignorance about a disease as prevalent as diabetes mellitus and the importance of educating the people about it.

kocarbon ag silver carbon wound dressing

Ger Your Free KoCarbon Ag Silver Wound Dressing For Diabetic Wounds

Durable Medical Equipment Provider of Service Schedule Fee Amount for 2016

INITIAL PHASE IN OF ADJUSTMENTS TO FEE SCHEDULE AMOUNTS FOR CERTAIN

Date
2015-11-23
Title
INITIAL PHASE IN OF ADJUSTMENTS TO FEE SCHEDULE AMOUNTS FOR CERTAIN
Contact
go.cms.gov/media

Updated December 8, 2015

INITIAL PHASE IN OF ADJUSTMENTS TO FEE SCHEDULE AMOUNTS FOR CERTAIN DMEPOS USING INFORMATION FROM THE COMPETITIVE BIDDING PROGRAM

On November 23, 2015, the Centers for Medicare & Medicaid Services (CMS) announced the release of the 2016 Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) fee schedule amounts.  The DMEPOS and Parenteral and Enteral Nutrition (PEN) public use files contain the 2016 fee schedule amounts for certain items that were adjusted based on information from the DMEPOS Competitive Bidding Program in accordance with sections 1834(a)(1)(F) and 1842(s)(3)(B) of the Social Security Act.  The following is information associated with this change.

DMEPOS Competitive Bidding Program

Section 302 of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) established requirements for a new competitive bidding program for certain DMEPOS items and services.  The statute requires that “single payment amounts” replace the current Medicare DMEPOS fee schedule payment amounts for selected DMEPOS items in certain areas of the country. The single payment amounts are determined by using bids submitted by DMEPOS suppliers.  The program is intended to set more appropriate DMEPOS payment amounts, which will reduce beneficiary out-of-pocket expenses and save the Medicare program money while ensuring beneficiary access to quality items and services.

There are currently competitive bidding programs in 99 Metropolitan Statistical Areas (MSAs) throughout the United States, including Honolulu, Hawaii.  DMEPOS items and services that have been phased in under the programs thus far include:

  • Oxygen and oxygen equipment
  • Continuous positive airway pressure (CPAP) devices, single and bi-level
  • Standard manual and power wheelchairs, scooters, and walkers
  • Group 2 complex rehabilitative power wheelchairs
  • Hospital beds, commode chairs, patient lifts, and seat lifts
  • Support surfaces or pressure reducing mattresses and overlays
  • Enteral nutrients, supplies, and equipment
  • Negative pressure wound therapy pumps
  • Infusion pumps
  • Transcutaneous electrical nerve stimulation (TENS) devices
  • Standard nebulizers

In addition, a national mail order program has been implemented for replacement of diabetic testing supplies such as test strips and lancets used with home blood glucose monitors.  The single payment amounts established under this program are also used to set the fee schedule amounts for these diabetic testing supplies when they are picked up at local pharmacies.

  • For information on DMEPOS Competitive Bidding

http://www.cms.gov/DMEPOSCompetitiveBid/

Payment for DMEPOS in Other Parts of the Country

Section 1834(a)(1)(F)(ii) of the Social Security Act requires use of information on the payment determined under the competitive bidding programs to adjust the fee schedule amounts that would otherwise be used in making payment for DME furnished outside of the competitive bidding areas (CBAs) for these items.  These adjustments must be made by no later than January 1, 2016.  This requirement provides savings for the program and all beneficiaries without having to establish competitive bidding programs throughout the entire United States.  Similarly, section 1842(s)(3)(B) of the Social Security Act provides discretion to use information on the payment determined under the competitive bidding programs to adjust the fee schedule amounts that would otherwise be used in making payment for enteral nutrients, supplies, and equipment furnished outside of the competitive bidding areas (CBAs) for these items.

Phase in of DMEPOS Fee Schedule Adjustments – The adjustments to the DMEPOS fee schedule rates will be phased in so that, during the initial 6 months of 2016, the fee schedule amounts in all areas will be based on a 50/50 blend of current rates and adjusted rates.  This will allow a 6-month transition period where health outcomes and access to these items and services can be closely monitored.

The general methodologies for adjusting the fee schedule amounts are described below and discussed in more detail in the final rule (CMS-1641-F):

1. Adjusted Fee Schedule Amounts for Areas within the Contiguous United States
For most DMEPOS items furnished in the contiguous United States, the adjustments to the fee schedule amounts will be made in different regions of the country based on information from competitive bidding programs conducted in each region.  The amount of variation in the regionally adjusted rates will be limited by a national ceiling equal to 110 percent of the average of the regionally adjusted rates, and a national floor equal to 90 percent of the average of the regionally adjusted rates.

Based on concerns raised by the public regarding the possible impact on access to DMEPOS items and services in rural areas of the country, the following rule was established:

Special Rule for Rural Areas – For an item or service included in 10 or more competitive bidding programs, a special rule was established for adjusting fee schedule amounts used in making payment for the item or service in areas within the contiguous United States that are defined as “rural” areas.  For the purpose of implementing this rule, a rural area is defined as a geographic area represented by a postal zip code if at least 50 percent of the total area included in the zip code is outside any MSA.  In addition, a rural area includes a geographic area represented by a postal zip code that is a low population density area excluded from a competitive bidding area.  For example, using authority in the statute, low population density areas in much of the eastern section of the Riverside-San Bernardino-Ontario MSA in California, were excluded from the CBA established for that MSA, and these areas are defined as rural areas for the purpose of implementing this rule.

For these areas, in no case will a fee schedule amount for any DMEPOS item furnished in the area be reduced below the national ceiling amount mentioned above.  For example, the regionally adjusted rate for January 2016 for oxygen and oxygen equipment for the region that includes the states of California, Nevada, Oregon, and Washington, is limited by the national floor amount mentioned above.  For all areas in these states that meet the definition of a rural area, the adjusted fee schedule amount for oxygen and oxygen equipment furnished in these areas will be set based on the national ceiling amount rather than the national floor amount, which is a 20 percent difference.

As noted above, the fee schedule amounts from January thru June of 2016 will be based on a 50/50 blend of current rates and adjusted rates, so the maximum difference between the fees for urban areas versus rural areas will not be realized until July 2016.

2. Adjusted Fee Schedule Amounts for Areas outside the Contiguous United States
Fee schedule amounts for areas outside the contiguous United States (i.e., noncontiguous areas such as Alaska, Hawaii, and Puerto Rico) are adjusted so that they are equal to the higher of the average of the (single payment) competitive bidding payment amounts for CBAs in areas outside the contiguous United States (currently only applicable Honolulu, Hawaii) or the national ceiling amount.
3. Adjusted Fee Schedule Amounts for Items Included in 10 or Fewer Areas 
Fee schedule amounts for DMEPOS items included in 10 or fewer CBAs are adjusted so that they are equal to 110 percent of the average of the competitive bidding payment amounts established for each of the areas. The average of the competitive bidding payment amounts will be a straight average and will not be weighted (e.g., based on the volume of items furnished in each of the competitive bidding areas). Items subject to this methodology as of January 2016, include commode chairs, nebulizers, infusion pumps, patient lifts, seat lifts, TENS devices, Group 2 complex rehabilitative power wheelchairs, and certain wheelchair accessories.  For these items, this methodology applies to all areas (i.e., non-contiguous and contiguous).
Examples of New Payment Rates for January

The table below lists average 2015 fees and average 2016 blended fees for the contiguous United States (both for urban areas and rural areas) for select items with the percentage change from 2015 to 2016:

Selected DMEPOS Items: Fees and Percentage Change from 2015 to 2016

DMEPOS Item HCPCS¹ 2015 Fee

2016 Blended Urban Fee

% change urban

2016 Blended Rural Fee

% change rural

Oxygen Concentrator (monthly) E1390

$180.92

$137.04

-24%

$141.74

-22%

CPAP (rental) E0601

$102.35

$74.55

-27%

$76.91

-25%

Hospital Bed (rental) E0260

$134.38

$102.53

-24%

$106.09

-21%

NPWT Pump (rental) E2402

$1,642.09

$1,219.48

-26%

$1,259.39

-23%

Manual Wheelchair (rental) K0001

$57.06

$41.69

-27%

$43.02

-25%

Power Wheelchair (rental) K0823

$577.42

$430.87

-25%

$445.20

-23%

Walker (purchase) E0143

$110.92

$82.14

-26%

$84.83

-24%

Commode Chair (purchase)² E0163

$119.05

$93.42

-22%

n/a

n/a

TENS (purchase)² E0730

$402.70

$290.40

-28%

n/a

n/a

Nebulizer (rental)² E0570

$17.86

$14.48

-19%

n/a

n/a

Powered Mattress (rental) E0277

$662.42

$451.74

-32%

$463.70

-30%

Insulin Pump (rental)² E0784

$465.19

$439.91

-5%

n/a

n/a

Enteral Pump (rental) B9002

$121.70

$93.15

-23%

$96.41

-21%

Enteral Supplies (daily) B4035

$11.95

$8.93

-25%

$9.23

-23%

Enteral Nutrients (per 100 calories) B4150-B4154

$1.12

$0.90

-20%

$0.93

-17%

¹ HCPCS = Healthcare Common Procedure Coding System; codes used to identify items for billing purposes

² Item included in 10 or fewer CBAs

The table below lists average 2015 fees and average 2016 blended fees for Alaska, Hawaii, Puerto Rico, and the U.S. Virgin Islands for select items with the percentage change from 2015 to 2016:

DMEPOS Item HCPCS 2015 Fee

2016 Blended Fee

% change

Oxygen Concentrator (monthly) E1390

$180.92

$145.61

-20%

CPAP (rental) E0601

$107.41

$80.75

-25%

Hospital Bed (rental) E0260

$134.38

$110.38

-18%

NPWT Pump (rental) E2402

$1,724.18

$1,331.09

-23%

Manual Wheelchair (rental) K0001

$58.64

$48.08

-18%

Power Wheelchair (rental) K0823

$591.86

$451.21

-24%

Walker (purchase) E0143

$121.13

$92.82

-23%

Commode Chair (purchase) E0163

$136.55

$103.12

-24%

TENS (purchase) E0730

$439.89

$310.43

-29%

Nebulizer (rental) E0570

$17.72

$14.41

-19%

Powered Mattress (rental) E0277

$673.00

$495.15

-26%

Insulin Pump (rental) E0784

$486.60

$451.44

-7%

Enteral Pump (rental) B9002

$121.70

$96.11

-21%

Enteral Supplies (daily) B4035

$11.95

$9.24

-23%

Enteral Nutrients (per 100 calories) B4150-B4154

$1.12

$0.93

-17%

Below are examples of average savings based on payments using the blended rates for the first 6 months of 2016 for three commonly used rental items: an oxygen concentrator (E1390), a hospital bed (E0260), and a powered pressure-reducing air mattress (E0277).

Oxygen concentrator payments for 6 months

Under the current fee schedule, the supplier is paid $1,086, on average, for furnishing an oxygen concentrator for 6 months, of which the beneficiary pays $217 in coinsurance payments. Beginning January 1, 2016, the supplier will be paid $822 for furnishing the concentrator in urban areas under the fee schedule and $850 for furnishing the concentrator in rural areas under the fee schedule. The beneficiary’s coinsurance will drop from $217 to $164 in the urban areas and from $217 to $170 in the rural areas.

Hospital bed payments for 6 months

Under the current fee schedule, the supplier is paid $705, on average, for furnishing a hospital bed for 6 months, of which the beneficiary pays $141 in coinsurance payments. Beginning January 1, 2016, the supplier will be paid $538 for furnishing the bed in urban areas under the fee schedule and $557 for furnishing the bed in rural areas under the fee schedule. The beneficiary’s coinsurance will drop from $141 to $108 in the urban areas and from $141 to $111 in the rural areas.

Powered mattress payments for6 months

Under the current fee schedule, the supplier is paid $3,478, on average, for furnishing a powered mattress for 6 months, of which the beneficiary pays $696 in coinsurance payments. Beginning January 1, 2016, the supplier will be paid $2,372 for furnishing the mattress and pump in urban areas under the fee schedule and $2,434 for furnishing the mattress and pump in rural areas under the fee schedule. The beneficiary’s coinsurance will drop from $696 to $474 in the urban areas and from $696 to $487 in the rural areas.

Monitoring the Impact of the Adjustments to the Fee Schedule Amounts

Currently, a very sophisticated, real-time claims and health outcomes monitoring program is used to ensure that access to necessary items and services is not negatively affected by the competitive bidding programs.  This program will be used to ensure that access to necessary DMEPOS items and services in non-CBAs of the country is not negatively affected by the initial blended rates during the 6-monthphase-in period.  This program will also continue to monitor to ensure that access is preserved after the phase-in period, when the full adjustments take place.

  • For information on the Competitive Bidding data monitoring program

https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/DMEPOSCompetitiveBid/Monitoring.html

Click here to order your free Silver Carbon Wound Dressing

Click here to order your free Silver Carbon Wound Dressing

halo mini negative pressure wound therapy pump system by equinox medical

Click the picture to learn more about the Halo MINI NPWT PUMP SYSTEM